Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV

The intestinal barrier has the daunting task of allowing nutrient absorption while limiting the entry of microbial products into the systemic circulation. HIV infection disrupts the intestinal barrier and increases intestinal permeability, leading to microbial product translocation. Convergent evidence has shown that gut damage and an enhanced level of microbial translocation contribute to the enhanced immune activation, the risk of non-AIDS comorbidity, and mortality in people living with HIV (PLWH). Gut biopsy procedures are invasive, and are not appropriate or feasible in large populations, even though they are the gold standard for intestinal barrier investigation. Thus, validated biomarkers that measure the degree of intestinal barrier damage and microbial translocation are needed in PLWH. Hematological biomarkers represent an objective indication of specific medical conditions and/or their severity, and should be able to be measured accurately and reproducibly via easily available and standardized blood tests. Several plasma biomarkers of intestinal damage, i.e., intestinal fatty acid-binding protein (I-FABP), zonulin, and regenerating islet-derived protein-3α (REG3α), and biomarkers of microbial translocation, such as lipopolysaccharide (LPS) and (1,3)-β-D-Glucan (BDG) have been used as markers of risk for developing non-AIDS comorbidities in cross sectional analyses and clinical trials, including those aiming at repair of gut damage. In this review, we critically discuss the value of different biomarkers for the estimation of gut permeability levels, paving the way towards developing validated diagnostic and therapeutic strategies to repair gut epithelial damage and to improve overall disease outcomes in PLWH.

[1]  L. Fischer,et al.  Recent advances in the application of microbial diamine oxidases and other histamine-oxidizing enzymes , 2022, World Journal of Microbiology and Biotechnology.

[2]  Hua Huang,et al.  Correlation between Intestinal Microflora in Irritable Bowel Syndrome and Severity , 2022, Disease markers.

[3]  M. Miyoshi,et al.  Presepsin production in monocyte/macrophage-mediated phagocytosis of neutrophil extracellular traps , 2022, Scientific Reports.

[4]  Madeleine Durand,et al.  Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population , 2022, Journal of the International Association of Providers of AIDS Care.

[5]  Yi-Qun Kuang,et al.  Pre-Digested Protein Enteral Nutritional Supplementation Enhances Recovery of CD4+ T Cells and Repair of Intestinal Barrier in HIV-Infected Immunological Non-Responders , 2021, Frontiers in Immunology.

[6]  Jian Guo,et al.  Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades. , 2021, Journal of pharmaceutical and biomedical analysis.

[7]  R. Madrid,et al.  Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status , 2021, Virulence.

[8]  K. Taskén,et al.  Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-Responders , 2021, Frontiers in Immunology.

[9]  W. Cao,et al.  HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies , 2021, Journal of immunology research.

[10]  S. Msika,et al.  Accuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia , 2021, Scientific Reports.

[11]  R. Heaton,et al.  Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV , 2021, Viruses.

[12]  Y. Furukawa,et al.  Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation , 2021, Microbiology spectrum.

[13]  S. Holland-Cunz,et al.  Citrulline, Biomarker of Enterocyte Functional Mass and Dietary Supplement. Metabolism, Transport, and Current Evidence for Clinical Use , 2021, Nutrients.

[14]  Lei Lei,et al.  The Serum Citrulline and D-Lactate are Associated with Gastrointestinal Dysfunction and Failure in Critically Ill Patients , 2021, International journal of general medicine.

[15]  K. Wimmers,et al.  Transcriptome analysis of porcine PBMCs reveals lipopolysaccharide-induced immunomodulatory responses and crosstalk of immune and glucocorticoid receptor signaling , 2021, Virulence.

[16]  P. Pérez-Matute,et al.  Lights and Shadows of Microbiota Modulation and Cardiovascular Risk in HIV Patients , 2021, International journal of environmental research and public health.

[17]  G. Donnarumma,et al.  Antimicrobial Peptides Human Beta-Defensin-2 and -3 Protect the Gut During Candida albicans Infections Enhancing the Intestinal Barrier Integrity: In Vitro Study , 2021, Frontiers in Cellular and Infection Microbiology.

[18]  J. Walter,et al.  Biomarkers for assessment of intestinal permeability in clinical practice. , 2021, American journal of physiology. Gastrointestinal and liver physiology.

[19]  J. Routy,et al.  Gut Leakage of Fungal‐Related Products: Turning Up the Heat for HIV Infection , 2021, Frontiers in Immunology.

[20]  C. Tremblay,et al.  Circulating β-D-Glucan as a marker of subclinical coronary plaque in ART-treated people living with HIV , 2021 .

[21]  A. d’Arminio Monforte,et al.  Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes , 2021, Frontiers in Immunology.

[22]  M. Osman,et al.  Fecal microbiota transplantation in HIV: A pilot placebo-controlled study , 2021, Nature Communications.

[23]  N. Chalasani,et al.  Blood Biomarkers of Intestinal Epithelium Damage Regenerating Islet-derived Protein 3α and Trefoil Factor 3 Are Persistently Elevated in Patients with Alcoholic Hepatitis. , 2021, Alcoholism, clinical and experimental research.

[24]  J. Lo,et al.  Gastrointestinal Dysfunction and HIV Comorbidities , 2021, Current HIV/AIDS Reports.

[25]  Ying Shen,et al.  Advances in the role and mechanism of zonulin pathway in kidney diseases , 2021, International Urology and Nephrology.

[26]  M. Kummen,et al.  Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction , 2020, The Journal of infectious diseases.

[27]  K. Kwiatkowska,et al.  TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling , 2020, Cellular and Molecular Life Sciences.

[28]  D. Levitt,et al.  Quantitative Evaluation of D-Lactate Pathophysiology: New Insights into the Mechanisms Involved and the Many Areas in Need of Further Investigation , 2020, Clinical and experimental gastroenterology.

[29]  J. Routy,et al.  Glucan rich nutrition does not increase gut translocation of beta‐glucan , 2020, Mycoses.

[30]  C. Tremblay,et al.  Anti-CMV IgG is linked to CD4 T-cell count decay in HIV elite controllers. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  C. Tremblay,et al.  Anti-cytomegalovirus Immunoglobulin G Is Linked to CD4 T-cell Count Decay in Human Immunodeficiency Virus (HIV) Elite Controllers , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  M. T. Veciana-Nogués,et al.  Histamine Intolerance: The Current State of the Art , 2020, Biomolecules.

[33]  T. Katsube,et al.  Citrulline, A Potential Biomarker of Radiation-Induced Small Intestine Damage , 2020, Dose-response : a publication of International Hormesis Society.

[34]  S. Svegliati,et al.  Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. , 2020, Rheumatology.

[35]  C. Libert,et al.  Glucocorticoids limit lipopolysaccharide‐induced lethal inflammation by a double control system , 2020, EMBO reports.

[36]  K. Überla,et al.  Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis , 2020, Nature Communications.

[37]  Lijuan Wang,et al.  A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice , 2020, Gut.

[38]  G. McComsey,et al.  Increased monocyte and T-cell activation in treated HIV+ ugandan children: associations with gut alteration and HIV factors. , 2020, AIDS.

[39]  W. Blattner,et al.  Elevated Plasma Levels of sCD14 and MCP-1 are associated with HIV Associated Neurocognitive Disorders among Antiretroviral Naïve Individuals in Nigeria. , 2020, Journal of acquired immune deficiency syndromes.

[40]  A. Fasano All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases , 2020, F1000Research.

[41]  D. Kaufmann,et al.  Daily variations of gut microbial translocation markers in ART-treated HIV-infected people , 2020, AIDS Research and Therapy.

[42]  R. Xu,et al.  Akkermansia muciniphila promotes type H vessel formation and bone fracture healing by reducing gut permeability and inflammation , 2020, Disease Models & Mechanisms.

[43]  G. McComsey,et al.  Altered intestinal permeability and fungal translocation in Ugandan children with HIV. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  V. Martel-Laferrière,et al.  Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  Katherine Rodriguez,et al.  Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity , 2019, Open forum infectious diseases.

[46]  J. Parienti,et al.  Cushing's syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case-control study in the French Pharmacovigilance Database. , 2019, The Journal of antimicrobial chemotherapy.

[47]  E. Tzanakakis,et al.  Four Decades After the Discovery of Regenerating Islet-Derived (Reg) Proteins: Current Understanding and Challenges , 2019, Front. Cell Dev. Biol..

[48]  B. Das,et al.  Homeostasis and dysbiosis of the gut microbiome in health and disease , 2019, Journal of Biosciences.

[49]  A. Forbes,et al.  Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill. , 2019, Anaesthesiology intensive therapy.

[50]  C. Tremblay,et al.  Plasma levels of C-type lectin REG3α and gut damage in people with HIV. , 2019, The Journal of infectious diseases.

[51]  Hong Chen,et al.  Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn's Disease , 2019, Gastroenterology research and practice.

[52]  N. Barnich,et al.  New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD , 2019, Autophagy.

[53]  Liping Zhao,et al.  Strain-Specific Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on Chronic Colitis in Mice , 2019, Front. Cell. Infect. Microbiol..

[54]  C. Libert,et al.  A General Introduction to Glucocorticoid Biology , 2019, Front. Immunol..

[55]  J. Langhorst,et al.  Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection , 2019, PloS one.

[56]  R. Seeley,et al.  Reg3 Proteins as Gut Hormones? , 2019, Endocrinology.

[57]  L. Munoz-Price,et al.  Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  S. Johnston,et al.  Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway , 2019, Scientific Reports.

[59]  R. Paredes,et al.  Evolution of the gut microbiome following acute HIV-1 infection , 2019, Microbiome.

[60]  R. Paredes,et al.  Evolution of the gut microbiome following acute HIV-1 infection , 2019, Microbiome.

[61]  M. Camilleri Leaky gut: mechanisms, measurement and clinical implications in humans , 2019, Gut.

[62]  C. Fichtenbaum,et al.  Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART , 2019, Pathogens & immunity.

[63]  Q. Qi,et al.  Gut microbial metabolites associated with HIV infection. , 2019, Future virology.

[64]  M. Ghannoum,et al.  Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV. , 2019, AIDS research and human retroviruses.

[65]  J. Routy,et al.  Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation , 2019, Front. Immunol..

[66]  E. Elamin,et al.  Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn’s Disease in a Three-dimensional Cell Culture Model , 2019, Scientific Reports.

[67]  Vanessa El Kamari,et al.  Brief Report: Gut Structural Damage an Ongoing Process in Chronically Untreated HIV Infection , 2019, Journal of acquired immune deficiency syndromes.

[68]  S. Chakraborty,et al.  Zinc ameliorates intestinal barrier dysfunctions in shigellosis by reinstating claudin-2 and -4 on the membranes. , 2019, American journal of physiology. Gastrointestinal and liver physiology.

[69]  M. Lederman,et al.  Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  T. Burdo,et al.  I-FABP Is Higher in People With Chronic HIV Than Elite Controllers, Related to Sugar and Fatty Acid Intake and Inversely Related to Body Fat in People With HIV , 2018, Open forum infectious diseases.

[71]  Shijie Geng,et al.  Fecal Microbiota Transplantation Beneficially Regulates Intestinal Mucosal Autophagy and Alleviates Gut Barrier Injury , 2018, mSystems.

[72]  M. V. D. van den Brink,et al.  Survival signal REG3&agr; prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease , 2018, The Journal of clinical investigation.

[73]  J. Lindsey,et al.  Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1–Infected Infants , 2018, The Journal of infectious diseases.

[74]  J. Routy,et al.  Use of (1→3)‐β‐d‐glucan for diagnosis and management of invasive mycoses in HIV‐infected patients , 2018, Mycoses.

[75]  M. Schaller,et al.  Candida albicans-Induced Epithelial Damage Mediates Translocation through Intestinal Barriers , 2018, mBio.

[76]  S. Luo,et al.  Emodin ameliorates ulcerative colitis by the flagellin‐TLR5 dependent pathway in mice , 2018, International immunopharmacology.

[77]  A. Forbes,et al.  Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis , 2018, United European gastroenterology journal.

[78]  K. Zengler,et al.  The Role of Intestinal C‐type Regenerating Islet Derived‐3 Lectins for Nonalcoholic Steatohepatitis , 2018, Hepatology communications.

[79]  J. Doré,et al.  Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis. , 2017, Gastroenterology.

[80]  M. Ghannoum,et al.  The mycobiome in HIV , 2018, Current opinion in HIV and AIDS.

[81]  J. Greenson,et al.  Survival signal REG 3 a prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease , 2018 .

[82]  R. Hendriks,et al.  A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. , 2018, Journal of autoimmunity.

[83]  M. Fischl,et al.  Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune Reconstitution Inflammatory Syndrome , 2017, The Journal of infectious diseases.

[84]  R. Gibbs,et al.  The gut mycobiome of the Human Microbiome Project healthy cohort , 2017, Microbiome.

[85]  N. Câmara,et al.  Intestinal barrier and gut microbiota: Shaping our immune responses throughout life , 2017, Tissue barriers.

[86]  C. Combescure,et al.  Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients , 2017, PloS one.

[87]  T. Silhavy,et al.  Outer Membrane Biogenesis. , 2017, Annual review of microbiology.

[88]  A. Akcan,et al.  Plasma citrulline measurement in the diagnosis of acute mesenteric ischaemia , 2017, ANZ journal of surgery.

[89]  I. A. Hajam,et al.  Bacterial flagellin—a potent immunomodulatory agent , 2017, Experimental &Molecular Medicine.

[90]  J. McCune,et al.  Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals , 2017, Gut microbes.

[91]  Jinli Wang,et al.  Glucocorticoids differentially regulate the innate immune responses of TLR4 and the cytosolic DNA sensing pathway , 2017, International immunopharmacology.

[92]  H. Tilg,et al.  Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease , 2017, Gut.

[93]  Hyeyoung Kim,et al.  The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases , 2017, International journal of molecular sciences.

[94]  H. Hallen-Adams,et al.  Fungi in the healthy human gastrointestinal tract , 2017, Virulence.

[95]  T. Katsuno,et al.  Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia , 2017, Clinical and translational gastroenterology.

[96]  Amit Kumar,et al.  Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs , 2017, Viruses.

[97]  A. Nakajima,et al.  Investigation of Small Bowel Abnormalities in HIV-Infected Patients Using Capsule Endoscopy , 2017, Gastroenterology research and practice.

[98]  H. Tilg,et al.  European consensus conference on faecal microbiota transplantation in clinical practice , 2017, Gut.

[99]  W. D. de Vos,et al.  Homeostasis of the gut barrier and potential biomarkers , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[100]  D. Kwon,et al.  HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation , 2016, Current opinion in infectious diseases.

[101]  W. Fawzi,et al.  Etiology of Diarrhea, Nutritional Outcomes, and Novel Intestinal Biomarkers in Tanzanian Infants , 2017, Journal of pediatric gastroenterology and nutrition.

[102]  S. Lynch,et al.  The Human Intestinal Microbiome in Health and Disease. , 2016, The New England journal of medicine.

[103]  M. Neurath,et al.  Successful therapy of Clostridium difficile infection with fecal microbiota transplantation. , 2016, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[104]  M. Finkelman,et al.  Gastrointestinal Leakage Detected by Serum (1→3)-&bgr;-D-Glucan in Mouse Models and a Pilot Study in Patients with Sepsis , 2016, Shock.

[105]  S. Gianella,et al.  (1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection? , 2016, Front. Immunol..

[106]  J. Garcia-Mazcorro,et al.  Thinking beside the box: Should we care about the non-coding strand of the 16S rRNA gene? , 2016, FEMS microbiology letters.

[107]  Lanjuan Li,et al.  Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population , 2016, Scientific Reports.

[108]  J. H. Schade,et al.  The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[109]  N. Zmora,et al.  The microbiome and innate immunity , 2016, Nature.

[110]  C. Tremblay,et al.  The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection , 2016, AIDS.

[111]  E. Lowenstein,et al.  Use of tumor necrosis factor (TNF) inhibitors in patients with HIV/AIDS. , 2016, Journal of the American Academy of Dermatology.

[112]  Roger N Gunn,et al.  Neuroinflammation in treated HIV-positive individuals , 2016, Neurology.

[113]  D. Douek,et al.  Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection , 2016, AIDS Research and Therapy.

[114]  M. Laue,et al.  Intestinal Cell Tight Junctions Limit Invasion of Candida albicans through Active Penetration and Endocytosis in the Early Stages of the Interaction of the Fungus with the Intestinal Barrier , 2016, PloS one.

[115]  L. McKinnon,et al.  Microbial translocation and microbiome dysbiosis in HIV-associated immune activation , 2016, Current opinion in HIV and AIDS.

[116]  R. Ellis,et al.  (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy , 2016, Medicine.

[117]  Jingjing Xiong,et al.  Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate. , 2016, Anti-cancer agents in medicinal chemistry.

[118]  S. Zimmerli,et al.  Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. , 2016, Swiss medical weekly.

[119]  D. Brenner,et al.  Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. , 2016, Cell host & microbe.

[120]  M. Oray,et al.  Long-term side effects of glucocorticoids , 2016, Expert opinion on drug safety.

[121]  Anumantha Kanthasamy,et al.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. , 2016, Pharmacology & therapeutics.

[122]  P. Bork,et al.  Gut Microbiota Linked to Sexual Preference and HIV Infection , 2016, EBioMedicine.

[123]  G. d’Ettorre,et al.  Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis , 2016, HIV clinical trials.

[124]  R. Ribeiro,et al.  Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques , 2016, PLoS pathogens.

[125]  S. Gianella,et al.  Correlation of (1→3)-β-D-glucan with other inflammation markers in chronically HIV infected persons on suppressive antiretroviral therapy , 2015, GMS infectious diseases.

[126]  M. D’Amato,et al.  Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea‐predominant irritable bowel syndrome , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[127]  A. Sönnerborg,et al.  Role of translocated bacterial flagellin in monocyte activation among individuals with chronic HIV-1 infection. , 2015, Clinical immunology.

[128]  T. Takayama,et al.  Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs , 2015, Journal of gastroenterology and hepatology.

[129]  J. Brenchley,et al.  Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial , 2015, PloS one.

[130]  R. Talukdar,et al.  Role of the normal gut microbiota. , 2015, World journal of gastroenterology.

[131]  P. Nowak,et al.  Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy. , 2015, AIDS research and human retroviruses.

[132]  F. Wang,et al.  A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[133]  C. Tremblay,et al.  Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection. , 2015, The Journal of infectious diseases.

[134]  Xiaoming Fan,et al.  Association of plasma diamine oxidase and intestinal fatty acid-binding protein with severity of disease in patient with heat stroke. , 2015, The American journal of emergency medicine.

[135]  B. Schnabl,et al.  Methods to determine intestinal permeability and bacterial translocation during liver disease. , 2015, Journal of immunological methods.

[136]  T. Weir,et al.  Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. , 2015, Cell host & microbe.

[137]  R. Bosch,et al.  Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286. , 2015, The Journal of infectious diseases.

[138]  R. Bruno,et al.  Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[139]  J. Margolick,et al.  The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation , 2015, AIDS.

[140]  A. Salem,et al.  Pharmacokinetic enhancement in HIV antiretroviral therapy: a comparison of ritonavir and cobicistat. , 2015, AIDS reviews.

[141]  Guoyao Wu,et al.  Glutamine and intestinal barrier function , 2015, Amino Acids.

[142]  Jeffrey N. Martin,et al.  UC Office of the President Recent Work Title The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD 4 + T cell recovery : a randomized crossover trial , 2014 .

[143]  M. Lederman,et al.  Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection. , 2014, The Journal of infectious diseases.

[144]  M. Lederman,et al.  Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. , 2014, The Journal of infectious diseases.

[145]  G. Corazza,et al.  Serum regenerating islet‐derived 3‐alpha is a biomarker of mucosal enteropathies , 2014, Alimentary pharmacology & therapeutics.

[146]  Todd M. Allen,et al.  Tumor necrosis factor α is associated with viral control and early disease progression in patients with HIV type 1 infection. , 2014, The Journal of infectious diseases.

[147]  B. Palmer,et al.  HIV-induced alteration in gut microbiota , 2014, Gut microbes.

[148]  S. Nielsen,et al.  Microbial translocation and cardiometabolic risk factors in HIV infection. , 2014, AIDS research and human retroviruses.

[149]  R. Ribeiro,et al.  Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication. , 2014, The Journal of clinical investigation.

[150]  A. Keshavarzian,et al.  A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects , 2014, PLoS pathogens.

[151]  B. Wiedenmann,et al.  Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[152]  A. Sönnerborg,et al.  Pattern of microbial translocation in patients living with HIV-1 from Vietnam, Ethiopia and Sweden , 2014, Journal of the International AIDS Society.

[153]  J. Sánchez-Payá,et al.  [Association between inflammatory markers and microbial translocation in patients with human immunodeficiency virus infection taking antiretroviral treatment]. , 2014, Medicina clinica.

[154]  K. Hanazaki,et al.  Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats , 2014, Medical Molecular Morphology.

[155]  Shashank Garg,et al.  Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection , 2013, PloS one.

[156]  B. Clotet,et al.  Immunodiscordant responses to HAART – mechanisms and consequences , 2013, Expert review of clinical immunology.

[157]  Paul M. Ruegger,et al.  HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota , 2013, Microbiome.

[158]  Matthew J. Gebert,et al.  Alterations in the gut microbiota associated with HIV-1 infection. , 2013, Cell host & microbe.

[159]  D. Richman,et al.  Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection , 2013, AIDS.

[160]  Ryan D. Hernandez,et al.  Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism , 2013, Science Translational Medicine.

[161]  M. Trøseid,et al.  Markers of microbial translocation predict hypertension in HIV‐infected individuals , 2013, HIV medicine.

[162]  C. Hirota,et al.  Attenuation of Clostridium difficile toxin‐induced damage to epithelial barrier by ecto‐5′‐nucleotidase (CD73) and adenosine receptor signaling , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[163]  B. Wiedenmann,et al.  Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[164]  E. Kuijper,et al.  Clostridium Difficile Infection in Patients with HIV/AIDS , 2013, Current HIV/AIDS Reports.

[165]  A. Walker,et al.  Therapeutic modulation of intestinal dysbiosis. , 2013, Pharmacological research.

[166]  M. Ciorba Indoleamine 2,3 dioxygenase in intestinal disease , 2013, Current opinion in gastroenterology.

[167]  G. Tack,et al.  Serum I‐FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies , 2013, Alimentary pharmacology & therapeutics.

[168]  A. Sönnerborg,et al.  Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy , 2013, PloS one.

[169]  G. Silvestri,et al.  Microbial Translocation in the Pathogenesis of HIV Infection and AIDS , 2013, Clinical Microbiology Reviews.

[170]  J. Brenchley,et al.  Microbial translocation, immune activation, and HIV disease. , 2013, Trends in microbiology.

[171]  C. Kessinger,et al.  Serum (1→3)-&bgr;-D-Glucan Levels in HIV-Infected Individuals Are Associated With Immunosuppression, Inflammation, and Cardiopulmonary Function , 2012, Journal of acquired immune deficiency syndromes.

[172]  E. Ruiz-Mateos,et al.  Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers. , 2012, The Journal of infection.

[173]  D. Douek,et al.  Microbial translocation in HIV infection: causes, consequences and treatment opportunities , 2012, Nature Reviews Microbiology.

[174]  Patrice D Cani,et al.  Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects , 2012, Brain, Behavior, and Immunity.

[175]  J. Murray,et al.  A Randomized, Double-Blind Study of Larazotide Acetate to Prevent the Activation of Celiac Disease During Gluten Challenge , 2012, The American Journal of Gastroenterology.

[176]  A. Sönnerborg,et al.  Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection , 2012, International journal of microbiology.

[177]  R. Spiller,et al.  Intestinal barrier function in health and gastrointestinal disease , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[178]  A. Tripathi,et al.  Larazotide acetate promotes tight junction assembly in epithelial cells , 2012, Peptides.

[179]  J. Murray,et al.  Larazotide acetate regulates epithelial tight junctions in vitro and in vivo , 2012, Peptides.

[180]  K. Hanazaki,et al.  Plasma Diamine Oxidase Activity Is a Useful Biomarker for Evaluating Gastrointestinal Tract Toxicities during Chemotherapy with Oral Fluorouracil Anti-Cancer Drugs in Patients with Gastric Cancer , 2012, Oncology.

[181]  M. Blaser,et al.  The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.

[182]  B. Schmidt,et al.  HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients , 2012, BMC Infectious Diseases.

[183]  F. Esposito,et al.  The HIV-1 Transactivator Factor (Tat) Induces Enterocyte Apoptosis through a Redox-Mediated Mechanism , 2011, PloS one.

[184]  D. Hommes,et al.  5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer , 2011, Gut.

[185]  Thomas M Braun,et al.  Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. , 2011, Blood.

[186]  S. Ahrné,et al.  Effect of Probiotic Bacteria on Microbial Host Defense, Growth, and Immune Function in Human Immunodeficiency Virus Type-1 Infection , 2011, Nutrients.

[187]  S. Danese New therapies for inflammatory bowel disease: from the bench to the bedside , 2011, Gut.

[188]  A. Manges,et al.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[189]  S. Lewin,et al.  Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial. , 2011, The Journal of infectious diseases.

[190]  E. Pamer,et al.  Role of the commensal microbiota in normal and pathogenic host immune responses. , 2011, Cell host & microbe.

[191]  H. Uno,et al.  Plasma sCD14 Is a Biomarker Associated With Impaired Neurocognitive Test Performance in Attention and Learning Domains in HIV Infection , 2011, Journal of acquired immune deficiency syndromes.

[192]  S. Lewin,et al.  Novel Sensitive Real-Time PCR for Quantification of Bacterial 16S rRNA Genes in Plasma of HIV-Infected Patients as a Marker for Microbial Translocation , 2011, Journal of Clinical Microbiology.

[193]  A. d’Arminio Monforte,et al.  Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count , 2011, AIDS.

[194]  S. de Bentzmann,et al.  The Pseudomonas aeruginosa opportunistic pathogen and human infections. , 2011, Environmental microbiology.

[195]  A. Daniele,et al.  Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn’s disease: preliminary report , 2011, International Journal of Colorectal Disease.

[196]  A. d’Arminio Monforte,et al.  Sequencing of bacterial microflora in peripheral blood: our experience with HIV-infected patients. , 2011, Journal of visualized experiments : JoVE.

[197]  Wei Sun,et al.  The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. , 2011, Cell metabolism.

[198]  N. Salzman,et al.  Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis , 2011, Nature Reviews Microbiology.

[199]  M. Clerici,et al.  Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial , 2011, Mucosal Immunology.

[200]  S. Lewin,et al.  Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection. , 2011, Biomarkers in medicine.

[201]  Philip Sutton,et al.  Mucin dynamics and enteric pathogens , 2011, Nature Reviews Microbiology.

[202]  Handan Wand,et al.  Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.

[203]  R. Compans,et al.  Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant , 2011, mBio.

[204]  T. Chiba,et al.  Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability , 2011, Inflammatory bowel diseases.

[205]  A. Fasano Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. , 2011, Physiological reviews.

[206]  A. Forbes,et al.  Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population. , 2010, Clinical nutrition.

[207]  C. Loddenkemper,et al.  Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect. , 2010, Gastroenterology.

[208]  J. Grivel,et al.  Contrasting Roles for TLR Ligands in HIV-1 Pathogenesis , 2010, PloS one.

[209]  G. Poli,et al.  Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. , 2010, The Journal of infectious diseases.

[210]  S. Pittaluga,et al.  Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections , 2010, PLoS pathogens.

[211]  D. Rubin,et al.  Human intestinal fatty acid binding protein 2 expression is associated with fat intake and polymorphisms. , 2010, The Journal of nutrition.

[212]  Jeff E. Mold,et al.  Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease , 2010, Science Translational Medicine.

[213]  T. Hope,et al.  Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation , 2010, PLoS pathogens.

[214]  R. Pecoits-Filho,et al.  Sevelamer Decreases Systemic Inflammation in Parallel to a Reduction in Endotoxemia , 2010, Blood Purification.

[215]  H. Fujii,et al.  [Intestinal fatty acid-binding protein (I-FABP) as a new biomarker for intestinal diseases]. , 2010, Rinsho byori. The Japanese journal of clinical pathology.

[216]  G. Kaplan,et al.  Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease , 2010, Alimentary pharmacology & therapeutics.

[217]  M. Raffatellu,et al.  Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm. , 2009, Cytokine.

[218]  A. Fasano,et al.  Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2 , 2009, Proceedings of the National Academy of Sciences.

[219]  Yunjin Jung,et al.  An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation. , 2009, European journal of pharmacology.

[220]  B. Jaber,et al.  Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[221]  C. Erridge,et al.  Bacteroides fragilis signals through Toll-like receptor (TLR) 2 and not through TLR4. , 2009, Journal of medical microbiology.

[222]  M. Tremblay,et al.  TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells. , 2009, Virology.

[223]  E. Levy,et al.  Localization, function and regulation of the two intestinal fatty acid-binding protein types , 2009, Histochemistry and Cell Biology.

[224]  Harry J. Flint,et al.  Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.

[225]  M. Lederman,et al.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. , 2009, The Journal of infectious diseases.

[226]  L. Frulloni,et al.  Antiflagellin antibodies recognize the autoantigens Toll‐Like Receptor 5 and Pals 1‐associated tight junction protein and induce monocytes activation and increased intestinal permeability in Crohn’s disease , 2009, Journal of internal medicine.

[227]  G. Fadda,et al.  Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[228]  M. Tremblay,et al.  TLR 5 stimulation is suf fi cient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD 4 + T cells , 2009 .

[229]  C. McClain,et al.  Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. , 2008, Alcohol.

[230]  C. Tincati,et al.  Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy , 2008, AIDS.

[231]  B. Jaber,et al.  Endotoxin-Binding Affinity of Sevelamer Hydrochloride , 2008, American Journal of Nephrology.

[232]  J. Jaroszewicz,et al.  Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis , 2008, Regulatory Peptides.

[233]  Jay K Kolls,et al.  Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut , 2008, Nature Medicine.

[234]  S. Pambuccian,et al.  Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. , 2008, The Journal of infectious diseases.

[235]  Jeffrey N. Martin,et al.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. , 2008, The Journal of infectious diseases.

[236]  Markus F Neurath,et al.  Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. , 2007, Gastroenterology.

[237]  A. Fasano,et al.  The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study , 2007, Alimentary pharmacology & therapeutics.

[238]  E. García-Martín,et al.  Genetic variability of human diamine oxidase: occurrence of three nonsynonymous polymorphisms and study of their effect on serum enzyme activity , 2007, Pharmacogenetics and genomics.

[239]  L. Cynober,et al.  Citrulline and the gut , 2007, Current opinion in clinical nutrition and metabolic care.

[240]  N. Novak,et al.  Histamine and histamine intolerance. , 2007, The American journal of clinical nutrition.

[241]  G Gerken,et al.  Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. , 2007, Gastroenterology.

[242]  D. Ye,et al.  Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[243]  M. Lederman,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.

[244]  W. Jaksch,et al.  Plasma D-lactate as a potential early marker for colon ischaemia after open aortic reconstruction. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[245]  D. Douek,et al.  HIV disease: fallout from a mucosal catastrophe? , 2006, Nature Immunology.

[246]  C. Hellerbrand,et al.  Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. , 2005, World journal of gastroenterology.

[247]  M. Markowitz,et al.  The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection. , 2005, The Journal of allergy and clinical immunology.

[248]  M. Müller,et al.  Low-dose prednisolone has a CD4-stabilizing effect in pre-treated HIV-patients during structured therapy interruptions (STI). , 2005, European journal of medical research.

[249]  S. Targan,et al.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. , 2005, Gastroenterology.

[250]  J. Auwerx,et al.  Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ , 2005, The Journal of experimental medicine.

[251]  M. Müller,et al.  Low dose prednisolone reduces CD4+ T cell loss in therapy-naive HIV-patients without antiretroviral therapy. , 2005, European journal of medical research.

[252]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[253]  J. Lalucat,et al.  Identification of culturable bacteria present in haemodialysis water and fluid. , 2005, FEMS microbiology ecology.

[254]  C. Streffer,et al.  Diamine oxidase activities in the large bowel mucosa of ulcerative colitis patients , 1990, Agents and Actions.

[255]  R. Mennigen,et al.  The intestinal diamine oxidase activity under the influence of adaptive proliferation of the intestinal mucosa — a proliferation terminating principle? , 1988, Agents and Actions.

[256]  O. Nielsen,et al.  Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid , 1987, Digestive Diseases and Sciences.

[257]  R. Schindler,et al.  Short bacterial DNA fragments: detection in dialysate and induction of cytokines. , 2004, Journal of the American Society of Nephrology : JASN.

[258]  W. D. de Vos,et al.  Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. , 2004, International journal of systematic and evolutionary microbiology.

[259]  D. Samuelson,et al.  Glutamine regulates Caco-2 cell tight junction proteins. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[260]  T. Savidge,et al.  Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[261]  W. Lu,et al.  Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection , 2004, BMC medicine.

[262]  A. Pedram,et al.  TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation , 2004 .

[263]  S. Targan,et al.  Bacterial flagellin is a dominant antigen in Crohn disease. , 2004, The Journal of clinical investigation.

[264]  E. Vossenaar,et al.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[265]  W. Hermens,et al.  Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. , 2003, Clinical biochemistry.

[266]  H. Redl,et al.  Increased Plasma D-Lactate is Associated with the Severity of Hemorrhagic/Traumatic Shock in Rats , 2003, Shock.

[267]  G. Wild,et al.  The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeability, mucosal TNFα production and nuclear factor kappa B expression , 2003, Alimentary pharmacology & therapeutics.

[268]  B. Messing,et al.  Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. , 2003, Gastroenterology.

[269]  F. Selvaggi,et al.  Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. , 2003, Gastroenterology.

[270]  B. Beutler,et al.  Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.

[271]  G. Coppa,et al.  Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. , 2002, Gastroenterology.

[272]  P. Rutgeerts,et al.  Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease , 2002, American Journal of Gastroenterology.

[273]  A. Krieg,et al.  Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes. , 2002, Antisense & nucleic acid drug development.

[274]  T. Sakaguchi,et al.  Shigella flexneri regulates tight junction‐associated proteins in human intestinal epithelial cells , 2002, Cellular microbiology.

[275]  C. Pothoulakis,et al.  Protein Kinase C Signaling Regulates ZO-1 Translocation and Increased Paracellular Flux of T84 Colonocytes Exposed toClostridium difficile Toxin A* , 2002, The Journal of Biological Chemistry.

[276]  C. Pothoulakis,et al.  Protein Kinase C Signaling Regulates ZO-1 Translocation and Increased Paracellular Flux of T84 Colonocytes Exposed to Clostridium difficile Toxin A* , 2002 .

[277]  D. Dooley,et al.  Human kidney diamine oxidase: heterologous expression, purification, and characterization , 2002, JBIC Journal of Biological Inorganic Chemistry.

[278]  G. Wild The mechanisms of prednisone inhibition of inflammation in Crohn?s disease involve changes in intestinal permeability, mucosal TNF$alpha; production and nuclear factor kappa B expression , 2001 .

[279]  Z. Sheng,et al.  Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats. , 2001, World journal of gastroenterology.

[280]  P. Verkade,et al.  Clostridium difficile Toxins Disrupt Epithelial Barrier Function by Altering Membrane Microdomain Localization of Tight Junction Proteins , 2001, Infection and Immunity.

[281]  K. Ishii,et al.  Human Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs1 2 , 2001, The Journal of Immunology.

[282]  F. Clayton,et al.  Enteric microtubule depolymerization in HIV infection: a possible cause of HIV-associated enteropathy. , 2001, AIDS.

[283]  A. Fasano,et al.  Human zonulin, a potential modulator of intestinal tight junctions. , 2000, Journal of cell science.

[284]  R. Schmid,et al.  Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β , 2000 .

[285]  Didier Raoult,et al.  16S Ribosomal DNA Sequence Analysis of a Large Collection of Environmental and Clinical Unidentifiable Bacterial Isolates , 2000, Journal of Clinical Microbiology.

[286]  C. Mackay,et al.  Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue , 2000, AIDS.

[287]  A. Fasano,et al.  Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease , 2000, The Lancet.

[288]  R. Schmid,et al.  Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. , 2000, Gastroenterology.

[289]  I. Fong,et al.  In vivo cytokine and neuroendocrine responses to endotoxin in human immunodeficiency virus-infected subjects. , 1999, The Journal of infectious diseases.

[290]  F. Belardelli,et al.  Human intestinal lamina propria lymphocytes are naturally permissive to HIV‐1 infection , 1999, European journal of immunology.

[291]  M. Gershwin,et al.  Immunopathogenesis of gastrointestinal and hepatobiliary diseases. , 1997, JAMA.

[292]  C. Winstanley,et al.  The bacterial flagellin gene as a biomarker for detection, population genetics and epidemiological analysis. , 1997, Microbiology.

[293]  A. Mowat,et al.  The anatomical basis of intestinal immunity , 1997, Immunological reviews.

[294]  J. Sacchettini,et al.  Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. , 1997, Surgery.

[295]  J. Scherberich,et al.  Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. , 1997, Journal of immunology.

[296]  G. Wu,et al.  An important role for endogenous synthesis of arginine in maintaining arginine homeostasis in neonatal pigs. , 1996, The American journal of physiology.

[297]  A. Krieg,et al.  Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. , 1996, Journal of immunology.

[298]  Simon Fleming,et al.  Comparative assessment of small intestinal and colonic permeability in HIV‐infected homosexual men , 1995, AIDS.

[299]  N. Liabakk,et al.  Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .

[300]  M. Wolvekamp,et al.  Diamine oxidase: an overview of historical, biochemical and functional aspects. , 1994, Digestive diseases.

[301]  N. Liabakk,et al.  Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters. , 1994, The Journal of infectious diseases.

[302]  N. Cerf-Bensussan,et al.  Intestinal intraepithelial lymphocytes. , 1991, Gastroenterology clinics of North America.

[303]  M. Zeitz,et al.  Human immunodeficiency virus-induced enteropathy , 1991, Immunologic research.

[304]  S. Rayfield The pitfalls of test reviews. , 1990, Advancing clinical care : official journal of NOAADN.

[305]  K. Bland,et al.  The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. , 1990, The Journal of surgical research.

[306]  R. Dowling,et al.  Is the intestine the sole source of heparin-stimulated plasma diamine oxidase? Acute effects of jejunectomy, ileectomy and total enterectomy. , 1990, Digestion.

[307]  M. Zeitz,et al.  Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. , 1989, Annals of internal medicine.

[308]  J. Harris,et al.  Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. , 1989, Journal of clinical pathology.

[309]  R. Markin,et al.  Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease. , 1988, The American journal of gastroenterology.

[310]  R. Eng,et al.  d-Lactic Acid Measurements in the Diagnosis of Bacterial Infections , 1986, The Journal of infectious diseases.

[311]  C. Wraight,et al.  Inhibition of intestinal citrulline synthesis causes severe growth retardation in rats. , 1985, The American journal of physiology.

[312]  W. Lorenz,et al.  Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. , 1983, Biochimica et biophysica acta.

[313]  J. Boyle,et al.  D-Lactic acidosis in children: an unusual metabolic complication of small bowel resection. , 1983, The Journal of pediatrics.

[314]  L. Stolberg,et al.  d-Lactic acidosis due to abnormal gut flora: diagnosis and treatment of two cases. , 1982, The New England journal of medicine.

[315]  H. G. Windmueller,et al.  Source and fate of circulating citrulline. , 1981, The American journal of physiology.

[316]  P. Burke,et al.  Diamine oxidase as a plasma marker of rat intestinal mucosal injury and regeneration after administration of 1-beta-D-arabinofuranosylcytosine. , 1981, Cancer research.

[317]  S. Baylin,et al.  Diamine oxidase (histaminase). A circulating marker for rat intestinal mucosal maturation and integrity. , 1980, The Journal of clinical investigation.

[318]  I. Llewellyn-Smith,et al.  The origin of citrulline-containing proteins in the hair follicle and the chemical nature of trichohyalin, an intracellular precursor. , 1977, Biochimica et biophysica acta.